Safety and efficacy of Interferon y in Friedreich ataxia, using clinical and paraclinical indicators of disease
收藏数据链接：
官方服务：
资源简介：
The data shared in the Zenodo repository include clinical and instrumental data from a randomized clinical trial open label phase II in Friedreich's Ataxia patients that underwent a 6 months treatment with interferone gamma and 6 months follow-up. Permission to use the data will be given only on direct request, correspondence to Prof. Andrea Martinuzzi ( andrea.martinuzzi@lanostrafamiglia.it ).
提供机构：
Zenodo创建时间：
2019-06-06
